The Pharmagellan Guide to Biotech Forecasting and Valuation

 

"Deserves a spot on the bookshelf of every biotech CFO."

BRUCE BOOTH, Partner, Atlas Ventures

 

"A helpful and insightful resource for anyone who finds themselves staring at a blank Excel spreadsheet."

ADAM FEUERSTEIN, Senior Columnist, TheStreet.com

 

"A fantastic plain-English guide ... unceasingly pragmatic. If you're trying to develop a reasonable view of the value of your program or company, this beautiful book breaks it down for you."

MICHAEL GILMAN, Serial Biotech CEO (Stromedix, Padlock)

 

"Invaluable, rigorously detailed, and well-validated."

- JOHN SULLIVAN, Director of Equity Research, Leerink Partners

 

"Pragmatic, credible advice ... this is the book I wish I'd had when I started out in the industry."

VIN MILANO, CEO, Idera Pharmaceuticals

 
  • xxx
  • xxx
  • xxx
  • xxx